Italy_Medical Information Specialist
Pubblicato il 02-09-2026 - Celltrion in Milano
Italy_Medical Information Specialist & PV Officer page is loaded## Italy_Medical Information Specialist & PV Officerlocations: Milantime type: Full timeposted on: Publicado há 30 dias ou maisjob requisition id: JR-00000178Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
La preghiamo di leggere attentamente le informazioni contenute in questo annuncio di lavoro per comprendere esattamente cosa ci si aspetta dai potenziali candidati.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world.
With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.We are searching for a brilliant Medical Information Specialist & PV Officer with a strong scientific background and a previous experience (at least two years)
in a similar role to join our Medical Affairs Department.The new colleague will be responsible for providing accurate, balanced, and evidence-based scientific and medical information regarding the Celltrion’s products to healthcare professionals (HCPs), patients, and internal stakeholders, the collection, assessment, documentation, and reporting of adverse events (AEs) serious and non-serious and other safety information related to the company’s medicinal products.Joining the Medical team and reporting to the Medical Manager, the new resource will be responsible for:MEDICAL INFORMATION SPECIALIST
* Answer to medical and scientific inquiries from healthcare professionals, patients, and internal teams in a timely and compliant manner;
* Develop and maintain Standard Response Letters and other medical information materials;
* Monitor scientific literature and ensure that responses and materials reflect the latest eviden